Genetic Technologies Stock Probability of Future Stock Price Finishing Over 2.49
| GENE Stock | USD 0.77 0.00 0.00% |
Genetic |
Genetic Technologies Target Price Odds to finish over 2.49
The tendency of Genetic Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 2.49 or more in 90 days |
| 0.77 | 90 days | 2.49 | close to zero percent |
Based on a normal probability distribution, the odds of Genetic Technologies to move over $ 2.49 or more in 90 days from now is close to zero percent (This Genetic Technologies probability density function shows the probability of Genetic Stock to fall within a particular range of prices over 90 days) . Probability of Genetic Technologies price to stay between its current price of $ 0.77 and $ 2.49 at the end of the 90-day period is about 70.8 .
Given the investment horizon of 90 days Genetic Technologies has a beta of -0.15. This usually indicates as returns on the benchmark increase, returns on holding Genetic Technologies are expected to decrease at a much lower rate. During a bear market, however, Genetic Technologies is likely to outperform the market. Additionally Genetic Technologies has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Genetic Technologies Price Density |
| Price |
Predictive Modules for Genetic Technologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genetic Technologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Genetic Technologies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Genetic Technologies is not an exception. The market had few large corrections towards the Genetic Technologies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Genetic Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Genetic Technologies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.21 | |
β | Beta against Dow Jones | -0.15 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.2 |
Genetic Technologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Genetic Technologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Genetic Technologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Genetic Technologies generated a negative expected return over the last 90 days | |
| Genetic Technologies has some characteristics of a very speculative penny stock | |
| Genetic Technologies has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 7.66 M. Net Loss for the year was (12.02 M) with profit before overhead, payroll, taxes, and interest of 6.01 M. | |
| Genetic Technologies currently holds about 11.74 M in cash with (9.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. | |
| Latest headline from investing.com: Genetic Technologies appoints voluntary administrators |
Genetic Technologies Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Genetic Stock often depends not only on the future outlook of the current and potential Genetic Technologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genetic Technologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 132.2 M | |
| Cash And Short Term Investments | 1 M |
Genetic Technologies Technical Analysis
Genetic Technologies' future price can be derived by breaking down and analyzing its technical indicators over time. Genetic Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Genetic Technologies. In general, you should focus on analyzing Genetic Stock price patterns and their correlations with different microeconomic environments and drivers.
Genetic Technologies Predictive Forecast Models
Genetic Technologies' time-series forecasting models is one of many Genetic Technologies' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Genetic Technologies' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Genetic Technologies
Checking the ongoing alerts about Genetic Technologies for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Genetic Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Genetic Technologies generated a negative expected return over the last 90 days | |
| Genetic Technologies has some characteristics of a very speculative penny stock | |
| Genetic Technologies has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 7.66 M. Net Loss for the year was (12.02 M) with profit before overhead, payroll, taxes, and interest of 6.01 M. | |
| Genetic Technologies currently holds about 11.74 M in cash with (9.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.76. | |
| Latest headline from investing.com: Genetic Technologies appoints voluntary administrators |
Check out Genetic Technologies Backtesting, Genetic Technologies Valuation, Genetic Technologies Correlation, Genetic Technologies Hype Analysis, Genetic Technologies Volatility, Genetic Technologies History as well as Genetic Technologies Performance. For information on how to trade Genetic Stock refer to our How to Trade Genetic Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genetic Technologies. If investors know Genetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genetic Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 2.19 | Quarterly Revenue Growth (0.11) | Return On Assets (0.63) | Return On Equity (1.85) |
The market value of Genetic Technologies is measured differently than its book value, which is the value of Genetic that is recorded on the company's balance sheet. Investors also form their own opinion of Genetic Technologies' value that differs from its market value or its book value, called intrinsic value, which is Genetic Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genetic Technologies' market value can be influenced by many factors that don't directly affect Genetic Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genetic Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Genetic Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genetic Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.